Zusammenfassung
Hintergrund
Wir untersuchten die prophylaktische präoperative Implantation einer intraaortalen Ballonpumpe (IABP) in herzchirurgischen Hochrisikopatienten mit einer additiven EuroSCORE-Summe ≥8.
Material und Methoden
Randomisierte Studie mit 104 Patienten, denen prophylaktisch keine IABP (Gruppe A, n=52) oder eine IABP (Gruppe B, n=52) implantiert wurde. Primärer Endpunkt war die 30-Tagessterblichkeit.
Ergebnisse
Das mediane Alter der Patienten betrug 74 Jahre und 43% der Patienten waren Frauen. Die 30-Tagessterblichkeit unterschied sich nicht (Gruppe A 17,3% versus Gruppe B 13,4%, p=0,78). Die mediane Klinikaufenthaltsdauer betrug in beiden Gruppen 14 Tage. In Gruppe A benötigten 13 Patienten (21%) intra- und postoperativ eine IABP-Unterstützung. Mediane Beatmungszeit (14 h versus 13 h), medianer Katecholaminbedarf, Häufigkeit eines akuten dialysepflichtigen Nierenversagens (28 versus 18%), kardiale Indizes und Häufigkeit eines „Low-cardiac-output“-Syndroms (26 versus 25%) waren zwischen den Gruppen nicht signifikant verschieden.
Schlussfolgerung
Die präoperative prophylaktische IABP-Implantation in EuroSCORE-stratifizierten Patienten ist nicht mit einer reduzierten 30-Tagessterblichkeit assoziiert.
Abstract
Background
We examined the impact of prophylactic IABP insertion in EuroSCORE-stratified high-risk cardiac surgery patients with a score ≥8.
Material and methods
A randomized trial with 104 patients either without prophylactic IABP insertion (group A, n=52) or with IABP (group B, n=52) was conducted. The primary endpoint was 30-day mortality.
Results
The median age of the patients was 74 years and 43% of participants were females. The 30-day mortality did not differ between group A (17.3%) and group B (13.4%; p=0.78). The median hospital stay was 14 days in both groups. Intra- and postoperative IABP support was required by 13 patients (21%) in group A. The median ventilation time (14 hours versus 13 hours), median catecholamine dose, frequency of dialysis-dependent acute renal failure (28% versus 18%), cardiac indices, and frequency of a low cardiac output syndrome (26% versus 25%) did not significantly differ between groups.
Conclusion
Prophylactic preoperative IABP insertion in EuroSCORE-stratified high-risk patients is not associated with decreased 30-day mortality.
Literatur
Buerke M, Lemm H, Dietz S, Werdan K (2010) Infarktbedingter kardiogener Schock: Ursache, Diagnose und Behandlung. Intensivmed Notfallmed 47:597–611
Christenson JT, Badel P, Simonet F et al (1997) Preoperative intraaortic balloon pump enhances cardiac performance and improves the outcome of redo CABG. Ann Thorac Surg 64:1237–1244
Christenson JT, Licker M, Kalangos A (2003) The role of intra-aortic counterpulsation in high-risk OPCAB surgery: a prospective randomized study. J Card Surg 18:286–294
Christenson JT, Simonet F, Badel P et al (1997) The effect of preoperative intra-aortic balloon pump support in patients with coronary artery disease, poor left-ventricular function (LVEF <40%), and hypertensive LV hypertrophy. Thorac Cardiovasc Surg 45:60–64
Christenson JT, Simonet F, Badel P et al (1997) Evaluation of preoperative intra-aortic balloon pump support in high risk coronary patients. Eur J Cardiothorac Surg 11:1097–1103
Christenson JT, Simonet F, Badel P et al (1999) Optimal timing of preoperative intraaortic balloon pump support in high-risk coronary patients. Ann Thorac Surg 68:934–939
Dunning J, Prendergast B (2003) Which patients would benefit from an intra-aortic balloon pump prior to cardiac surgery? Interact Cardiovasc Thorac Surg 2:416–419
Dyub AM, Whitlock RP, Abouzahr LL et al (2008) Preoperative intra-aortic balloon pump in patients undergoing coronary bypass surgery: a systematic review and meta-analysis. J Card Surg 23:79–86
Ferguson JJ 3rd, Cohen M, Freedman RJ Jr et al (2001) The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. J Am Coll Cardiol 38:1456–1462
Field Ml, Rengarajan A, Khan O et al (2007) Preoperative intra aortic balloon pumps in patients undergoing coronary artery bypass grafting. Cochrane Database Syst Rev:CD004472
Gummert JF, Funkat A, Beckmann A et al (2009) Cardiac surgery in Germany during 2008. A report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 57:315–323
Gutfinger DE, Ott RA, Miller M et al (1999) Aggressive preoperative use of intraaortic balloon pump in elderly patients undergoing coronary artery bypass grafting. Ann Thorac Surg 67:610–613
Holman Wl, Li Q, Kiefe CI et al (2000) Prophylactic value of preincision intra-aortic balloon pump: analysis of a statewide experience. J Thorac Cardiovasc Surg 120:1112–1119
Kantrowitz A, Tjonneland S, Freed PS et al (1968) Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA 203:113–118
Lorusso R, Gelsomino S, Carella R et al (2010) Impact of prophylactic intra-aortic balloon counter-pulsation on postoperative outcome in high-risk cardiac surgery patients: a multicentre, propensity-score analysis. Eur J Cardiothorac Surg
Nashef SA, Roques F, Michel P et al (1999) European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16:9–13
Nilsson J, Algotsson L, Hoglund P et al (2006) Comparison of 19 pre-operative risk stratification models in open-heart surgery. Eur Heart J 27:867–874
Parolari A, Pesce LL, Trezzi M et al (2010) EuroSCORE performance in valve surgery: a meta-analysis. Ann Thorac Surg 89:787–793, 793.e1–2
Prondzinsky R, Lemm H, Swyter M et al (2010) Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med 38:152–160
Santa-Cruz RA, Cohen MG, Ohman EM (2006) Aortic counterpulsation: a review of the hemodynamic effects and indications for use. Catheter Cardiovasc Interv 67:68–77
Sjauw KD, Engstrom AE, Vis MM et al (2009) A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 30:459–468
Trost JC, Hillis LD (2006) Intra-aortic balloon counterpulsation. Am J Cardiol 97:1391–1398
Trummer G, Beyersdorf F (2003) Aortale Gegenpulsationspumpe und implantierbare supportive Kreislaufsysteme. Intensivmed Notfallmed 40:618–622
Van De Werf F, Bax J, Betriu A et al (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 29:2909–2945
Werner GS (2004) Einsatz der intraortalen Ballongegenpulsation (IABP) beim kardialen Schock in Deutschland: Erfordernis und Wirklichkeit. Intensivmed Notfallmed 41:517–523
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Metz, D., Stiller, M., Silber, RE. et al. Prophylaktische intraaortale Ballongegenpulsation bei herzchirurgischen Hochrisikopatienten. Med Klin 106, 125–131 (2011). https://doi.org/10.1007/s00063-011-0048-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00063-011-0048-z